Sequential Functional and Morphological Alterations During Hepatocarcinogenesis Induced in Rats by Feeding of a Low Dose of 2-Acetylaminofluorene

Abstract

The early cellular events in liver carcinogenesis were studied in Fischer-344 male rats that either were fed 200 ppm 2-acetylaminofluorene (AAF) for up to 10 wk or were fed the carcinogen for 8 wk followed by maintenance for an additional 24 wk. By 1 wk of exposure, AAF caused a reduction in the number of glutamine synthetase (GS)-positive centrilobular hepatocytes, an increase in DNA synthesizing hepatocytes in the central areas of the hepatic lobules, and a shift from multinucleated to mononucleated hepatocytes, although overt hepatocellular necrosis was not evident. By 3 wk, altered hepatocellular foci characterized by deficiencies in iron storage (IS^-) and collagen production and by expression of gamma-glutamyl transferase (GGT⁺) and placental-type glutathione transferase (PGT⁺) activity appeared. Single PGT+ cells were also found. During continued exposure, foci increased in number, size, and total area with the increases escalating between 8 and 10 wk of exposure. Cessation of AAF exposure at 8 wk resulted in a slight decrease in the number of foci after a further 6 wk of maintenance, but with continued maintenance for another 6 and 12 wk, the number again increased. IS^- characterized the majority of foci during carcinogen administration, whereas after cessation of exposure, GGT+ and PGT+ foci predominated. None of the foci were positive for GS. After AAF exposure for 10 wk, a few neoplasms developed and greater numbers occurred after maintenance for a further 24 wk of rats exposed for 8 wk. We conclude the following: (a) the low dose of AAF caused subtle alterations in function and proliferation of normal hepatocytes and converted hepatocytes into focus cells; (b) reduction of the GS+ area is a sensitive indicator of cytotoxicity of AAF; (c) the development of some foci at an early stage depends on a promoting action of AAF, which ceased when the carcinogen was withdrawn, allowing some foci to undergo reversion; (d) a strong linkage exists in expression of IS-, GGT+, and PGT+ in foci; (e) the carcinogenic process accelerates in the absence of any indication of increased cytotoxicity by AAF; and (f) under the conditions of this study, no GS+ foci, adenomas, and carcinomas were found, indicating that no carcinogen-induced expression of GS occurred in these lesions and that GS expression is not linked to other phenotypic abnormalities.

Keywords

Cell proliferation preneoplasia cytotoxicity

References

Bursch W. , Lauer B. , Timmermann-Trosiener I. , Barthel G. , Schuppler J. , and Schulte-Hermann R. (1984). Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453-458.

Bursch W. , Taper HS , Lauer B. , and Schulte-Hermann R. (1985). Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. (Cell Pathol.) 50: 153-166.

Bursch W. and Schulte-Hermann R. (1988). Cell death (apoptosis) in normal and preneoplastic liver tissue. In: Experimental Hepatocarcinogenesis, MB Roberfroid and V Preat (ed). Plenum Press, New York, pp. 143-159.

Columbano A. , Ledda-Columbano GM , Rao PM , Rajalkshmi S. , and Sarma DSR (1984). Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study . Am. J. Pathol . 116: 441-446.

Enzman H. and Bannasch P. (1988). Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine. J. Cancer Res. Clin. Oncol. 115: 30-34.

Furuya K. , Maeura Y. , and Williams GM (1984). Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action. Toxicol. Pathol. 12: 136-142.

Gebhardt R. and Burger H. -J (1987). Selective loss of hormonal induction of glutamate transport in primary cultures of hepatocytes from rats treated with CCI4. J. Hepatol. 4: 381-389.

Gebhardt R. , Burger H. -J, Heini H. , Schreiber KL , and Mecke D. (1988). Alterations of hepatocyte enzyme levels and of the acinar distribution of glutamine synthetase in response to experimental liver injury in the rat. Hepatology 8: 822-830.

Gebhardt R. and Mecke D. (1983). Heterogenous distribution of glutamine synthetase among rat liver parenchymal cells in situ and in primary culture. EMBO J. 2: 567-570.

10.

Gebhardt R. , Tanaka T. , and Williams GM (1989). Glutamine synthetase heterogenous expression as a marker for the cellular lineage of preneoplastic and neoplastic liver populations. Carcinogenesis 10: 1917-1923.

11.

Gebhardt R. and Williams GM (1988). A new aspect of liver carcinogenesis: Selective induction of glutamine-synthetase-positive liver carcinomas by carcinogens which affect hepatocytes expressing this phenotype. In: Advances in Ammonia Metabolism and Hepatic Encephalopathy, PB Soeters , JHP Wilson , AJ Meijer , and E Holm (ed). Elsevier, Amsterdam , pp. 581-586.

12.

Germain L. , Goyette R. , and Marceau N. (1985). Differential cytokeratin and a-fetoprotein expression in morphologically distinct epithelial cells emerging at the early stage of rat hepatocarcinogenesis. Cancer Res. 45: 673-681.

13.

Hacker HJ , Moore MA , Mayer D. , and Bannasch P. (1982). Correlative histochemistry of some enzymes of carbohydrate metabolism in preneoplastic and neoplastic lesions in the rat liver. Carcinogenesis 3: 1265-1272.

14.

Hirota N. and Williams GM (1979). Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure. J. Natl. Cancer Inst. 63: 1257-1265.

15.

Hirota N. and Williams GM (1979). The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am. J. Pathol. 95: 317-328.

16.

Hirota N. and Williams GM (1982). Ultrastructural abnormalities in carcinogen-induced hepatocellular foci identified by resistance to iron accumulation. Cancer Res. 42: 2298-2309.

17.

Hoel DG , Haseman JK , Hogan MD , Huff J. , and McConnell EE (1988). The impact of toxicity on carcinogenic studies: Implications for risk assessment. Carcinogenesis 9: 2045-2052.

18.

Kitagawa T. (1971). Histochemical analysis of hyperplastic lesions and hepatomas of the liver of rats fed 2-fluorenylacetamide . Gann 62: 205-214.

19.

Maruyama H. , Tanaka T. , Gebhardt R. , Berghem L. , and Williams GM (1988). Decreased fibronectin in rat liver altered foci and adenomas induced by N-2-fluorenylacetamide . Lab. Invest. 58: 630-635.

20.

Mori H. , Tanaka T. , Sugie S. , Takashashi M. , and Williams GM (1982). DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J. Natl. Cancer Inst. 69: 1277-1282.

21.

Pitot HC and Sirica AE (1980). The stages of initiation and promotion in hepatocarcinogenesis . Biochim. Biophys. Acta 605: 191-215.

22.

Rabes HM , Scholze P. , and Jantsch B. (1972). Growth kinetics of dimethylnitrosamine-induced, enzyme-deficient "preneoplastic" liver cell populations in vivo and in vitro . Cancer Res. 32: 2577-2586.

23.

Rabes HM and Szymkowiak R. (1979). Cell kinetics of hepatocytes during the preneoplastic period of dimethylnitrosamine-induced liver carcinogenesis. Cancer Res. 29: 1298-1304.

24.

Rutenburg AM , Kim H. , Fischbein JW , Hanker JS , Wasserkrug HL , and Seligman AM (1969). Histochemical and ultrastructural demonstration of gamma-glutamyl transpeptidase activity. J. Histochem. Cytochem. 17: 517-526.

25.

Saeter G. , Schwartze PE , Nesland JM , Juul N. , Pettersen EO , and Seglen PO (1988). The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas. Carcinogenesis 9: 939-945.

26.

Scherer E. (1984). Neoplastic progression in experimental hepatocarcinogenesis . Biochim. Biophys. Acta 738: 219-236.

27.

Schulte-Hermann R. , Timmermann-Trosiener I. , and Schuppler J. (1986). Facilitated expression of adaptive responses to phenobarbital in putative pre-stages of liver cancer. Carcinogenesis 7: 1651-1655.

28.

Seglen PO , Schwartze PE , and Saeter G. (1986). Changes in cellular ploidy and autophagic responsiveness during rat liver carcinogenesis. Toxicol. Pathol. 14: 342-348.

29.

Sell S. and Dunsford HA (1989). Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am. J. Pathol. 124: 1347-1363.

30.

Stenbäck F. , Saarni H. , Rautio A. , StengÅard J. , and Sotaniemi E. (1989). Reversibility of rat liver cirrhosis by medroxyprogesterone acetate. Toxicol. Pathol. 17: 38-45.

31.

Stenbäck F. and Wasenius V-M. (1985). Basement membrane structures in tumors of the ovary. Eur. J. Obstet. Gynecol. Reprod. Biol. 20: 357-371.

32.

Stewart HL , Williams G. , Keysser CH , Lombard LS , and Montali RJ (1980). Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst. 64: 177-206.

33.

Tong CC and Williams GM (1987). The effect of tumor promoters on cell-to-cell communication in liver epithelial cell systems. In: Biochemical Mechanisms and Regulation of Intercellular Communication, HA Milman and E Elmore (eds). Princeton Scientific, Princeton, New Jersey, pp. 255-263.

34.

Trosko JE , Yotti LP , Dawson B. , and Chang C-C. (1981). In vitro assay for tumor promoters. In: Short-Term Tests for Chemical Carcinogens, HF Stich and RHC San (eds). Springer-Verlag, New York, pp. 420-427.

35.

Umemura T. , Tokumo K. , Gebhardt R. , Poirier M. , and Williams GM (1993). Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett. 73: 1-10.

36.

Watanabe K. and Williams GM (1978). Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst. 61: 1311-1314.

37.

Weibel ER and Bolender RP (1973). Stereological techniques for electron microscopy morphometry. In: Principles and Techniques of Electron Microscopy, Vol. 3, MA Hayat (ed). Nostrand, New York, pp. 237-294.

38.

Weisburger EK , Weisburger JH , and Morris HP (1958). Chemistry carcinogenicity, and metabolism of 2-fluoremamine and related compounds . Adv. Cancer Res. 5: 431.

39.

Wilison RH , DeEds F. , and Cox AJ Jr (1941). The toxicity and carcinogenic activity of 2-acetylaminofluorene. Cancer Res. 1: 595-608.

40.

Williams GM (1976). Functional markers and growth behavior of preneoplastic hepatocytes. Cancer Res. 36: 2540-2543.

41.

Williams GM (1980). The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta 605: 167-189.

42.

Williams GM (1981). Liver carcinogenesis. The role for some chemicals of an epigenetic mechanism of liver tumour promotion involving modification of the cell membrane. Food Cosmetics Toxicol. 19: 577-583.

43.

Williams GM (1990). Epigenetic mechanisms in liver tumor promotion . In: Mouse Liver Carcinogenesis. Mechanisms and Species Comparison , DE Stephen-son et al (eds). Alan R. Liss, New York, pp. 131-145.

44.

Williams GM , Gebhardt R. , Shirma H. , and Stenbäck F. (1993). Non-linearity of neoplastic conversion induced in rat liver by low exposures to dimethylnitrosamine. Carcinogenesis 14: 2149-2156.

45.

Williams GM , Hiorta N. , and Rice JM (1979). The resistance of spontaneous mouse hepatocellular neoplasms to iron accumulation during rapid iron loading by parenteral administration and their transplant-ability . Am. J. Pathol. 94: 65-74.

46.

Williams GM , Klaiber M. , Parker SE , and Farber E. (1976). Nature of early appearing carcinogen-induced liver lesions resistant to iron accumulation. J. Natl. Cancer Inst. 57: 157-165.

47.

Williams GM and Watanabe K. (1978). Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J. Natl. Cancer Inst. 61: 113-121.

48.

Williams GM and Weisburger JH (1991). Chemical carcinogenesis. In: Casarett and Doull's Toxicology: The Basic Sciences of Poisons, 4th ed, MO Amdur , J Doull , and CD Klaassen (eds). Pergamon Press, New York , pp. 127-200.

49.

Williams GM and Yamamoto RS (1972). Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis. J. Natl. Cancer Inst . 49: 685-694.

50.

Yamamoto RS , Williams GM , Frankel HH , and Weisburger JH (1971). 8-hydroxyquinoline: Chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol. Appl. Pharmacol. 19: 687-698.